Company Profile
Ambu A/S is a Denmark-based manufacturer of single-use endoscopes and respiratory care solutions, headquartered in Ballerup, Denmark. Founded in 1937 by Holger Hesse and Henning Ruben, the company operates as a publicly listed entity on Nasdaq Copenhagen (AMBU B), serving global endoscopy and anesthesia markets in over 60 countries with a workforce of 5,200+ employees.
Core Products ＆ Technologies
Single-Use Endoscopy
• aScope 5 Broncho: Single-use bronchoscope for airway management, ICU procedures, and bedside diagnostics
• aScope 4 Cysto: Single-use flexible cystoscope for urological examinations and stent removal
• aScope 4 RhinoLaryngo: Single-use ENT endoscope for ear, nose, and throat diagnostics
• aScope Duodeno: Single-use duodenoscope for ERCP procedures, eliminating cross-contamination risks
• aScope Gastro Large: Therapeutic gastroscope combining 4.2mm channel power with standard gastroscope manoeuvrability
Visualization ＆ Airway Management
• SureSight Connect: Video laryngoscope integrating with Ambu endoscopy systems for dual-view intubation and bronchoscopy
• SureSight Mobile: Portable, ready-handed video laryngoscope with built-in screen for emergency and ward settings
• SureSight Blades: Range of 10 single-use blades in adult and pediatric sizes, including hyperangulated options
• Ambu Bag: Self-inflating resuscitator for emergency ventilation and anesthesia support
Patient Monitoring ＆ Digital Health
• BlueSensor: Electrocardiography electrodes for diagnostic and monitoring applications
• EndoIntelligence: Data-driven platform for endoscopy workflow optimization and operational efficiency
• Ambu Recircle: Endoscope recycling program supporting hospital waste reduction and carbon footprint goals
Market Position ＆ Certifications
Ambu holds a global leadership position in the single-use endoscopy market with an estimated 60%+ market share, competing with Olympus Corporation, Boston Scientific, Pentax Medical (HOYA Corporation), and Karl Storz SE ＆ Co. KG. Key strengths include:
• 89 years of Danish engineering heritage in resuscitation and endoscopy innovation
• Market leadership: Most comprehensive single-use endoscopy portfolio globally, a market created by Ambu in 2009
• Regulatory compliance: CE marked, FDA cleared, and registered by major global health authorities
• Global manufacturing footprint: Four factories across Europe, North America (Mexico), and Asia Pacific (Malaysia)
• Design excellence: SureSight won the Red Dot Award: Product Design 2026; aScope 4 Cysto and aScope Duodeno won Red Dot in 2021
Corporate Timeline
1937 — Founded in Denmark with the invention of the Ambu Bag resuscitator
1995 — Listed on Nasdaq Copenhagen (AMBU B)
2009 — Created the single-use endoscopy market with launch of first single-use flexible endoscope
2025 — Launched SureSight video laryngoscope in the US and UK markets
2026 — SureSight received CE mark in Europe (April) and won Red Dot Award: Product Design 2026 (April); initiated DKK 300m share buyback program (May); accelerated Mexico manufacturing ramp-up to support North America growth and tariff mitigation
Target Markets ＆ Applications
• Respiratory Endoscopy: aScope 5 Broncho and SureSight portfolio for airway management, ICU diagnostics, and intubation across OR, ICU, and EMS settings
• Urology ＆ ENT: aScope 4 Cysto and aScope 4 RhinoLaryngo for outpatient diagnostic and procedural workflows
• Gastroenterology: aScope Duodeno for ERCP and biliary interventions without reprocessing overhead; aScope Gastro Large for therapeutic GI procedures
• Emergency ＆ Anesthesia: Ambu Bag resuscitators, patient monitoring electrodes, and SureSight Mobile for pre-hospital and OR settings
Contact Information
Global Headquarters
Address: Baltorpbakken 13, DK-2750 Ballerup, Denmark
Telephone: +45 7225 2000
Email: ambu@ambu.com
Corporate Status
Entity Type: Publicly Listed Company (No Parent Company)
Stock: Nasdaq Copenhagen: AMBU B
Website: ambu.com
Investor Relations: investor.ambu.com
